Takeda Pharmaceutical Company Limited Price to Earnings Ratio (PE) Ratios, (TAK) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket
 




Takeda Pharmaceutical Company Limited  (NYSE: TAK)
 





TAK Price to Earnings Ratio Current (Mar 31 2024) (Mar 31 2023)
Diluted EPS 12 Trailing Months IV. Quarter IV. Quarter
PE (TTM) Ratio current            43.08            23.30            11.38            11.38            11.38
Diluted EPS TTM Y / Y Change -31.26 % -55.39 % - % - % - %
Diluted EPS Y / Y Change - % -55.43 % - % - % - %
Stock performance to date 39.51 % -3.14 % 4.57 %

Price to earnings ratio Comment
Takeda Pharmaceutical Company Limited's current Price to earnings ratio has increased due to shareprice growth of 39.51 %, from beginning of IV. Quarter and due to eps contraction of 0 %, to Pe of 43.08, from average Price to earnings ratio in IV. Quarter of 23.30.

Within Healthcare sector 175 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Takeda Pharmaceutical Company Limited Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #69
Sector #176
S&P 500 #2061





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.